captopril has been researched along with verapamil in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (33.72) | 18.7374 |
1990's | 34 (39.53) | 18.2507 |
2000's | 14 (16.28) | 29.6817 |
2010's | 9 (10.47) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Das, AM; Harris, DA | 1 |
Bulpitt, C; Fletcher, A | 1 |
Aronica, A; Carzaniga, G; Catalano, M; Cislaghi, C; Libretti, A; Seregni, R | 1 |
Geller, AL; Goldabin, VI; Goloshchapov, OA; Mashin, AA; Rud', SS | 1 |
Göransson-Nyberg, A; Hansell, P; Sjöquist, M; Ulfendahl, HR | 1 |
Carotenuto, A; De Divitiis, O; Di Somma, S; Liguori, V; Paulucci, A; Petitto, M | 1 |
Clark, R; Gupta, AK; Kirchner, KA | 1 |
Ahonen, A; Riska, H; Salorinne, Y; Sovijärvi, AR; Stenius-Aarniala, B; Sundberg, S | 1 |
Baumgartner, HR; Hefti, F; Kuhn, H; Müller, RK; Powell, JS; Rouge, M | 1 |
Galey-Arcangioli, C; Imbs, JL; Maarek-Charbit, M; Stephan, D; Welsch, M | 1 |
Atlan, JP; Bouche, JM; Ceccaldi, JP; Drici, MD; Giacomoni, S; Halimi, G; Lapalus, P; Morand, P; Passeron-Seître, M; Teboul, B | 1 |
Blantz, RC; De Nicola, L; Gabbai, FB | 1 |
Toshima, H | 1 |
Curry, C; Gray, J; Hollifield, J; Kong, BW; Saunders, E; Schoenberger, J; Sowers, JR; Vertes, V; Weir, MR; Zemel, MB | 1 |
Baume, RM; Croog, SH; Kong, BW; Levine, S; Saunders, E; Weir, MR | 1 |
Ram, CV | 1 |
Eisen, V; Munday, MR; Slater, JD | 2 |
Riska, H; Sovijärvi, AR; Stenius-Aarniala, B | 1 |
Dandona, P; Gill, J; Jeremy, J | 1 |
Bolli, P; Brouwer, RM; Bühler, FR; Conen, D; Erné, P; Kiowski, W | 1 |
Littler, WA; Smith, SA | 1 |
Champion, WJ; Navar, LG; Thomas, CE | 1 |
Koster, M | 1 |
Markiewicz, M; Rymar, B; Trojnar, R; Wysokiński, A | 1 |
Anaise, D; Lane, B; Rapaport, FT; Waltzer, WC | 1 |
Barros, EJ; Boim, MA; Draibe, SA; Ramos, OL; Schor, N; Sigulem, D | 1 |
Herman, A; Laekman, G; Lámeire, N; Vanholder, R | 1 |
Ferrara, AL; Marotta, T; Pasanisi, F | 1 |
Heagerty, AM; Swales, JD | 1 |
Ajzen, H; Barros, EJ; Boim, MA; Ramos, OL; Schor, N | 1 |
Riska, H; Sovijärvi, AR; Stenius-Aaniala, B | 1 |
Huang, WC | 1 |
Bean, BL; Loeb, AL | 1 |
Anaise, D; Lane, B; Ramsammy, L; Rapaport, FT; Waltzer, WC | 1 |
García-Iglesias, C; López-Novoa, JM; Macias-Nuñez, JF; Santos, JC; Sanz, E | 1 |
Pflederer, W | 1 |
Anand, MP | 1 |
Johnston, CI | 1 |
Angelini, A; Dario, C; Mazzucato, A; Pauletto, P; Pessina, AC; Scannapieco, G; Semplicini, A; Vescovo, G | 1 |
Brunner, HR; Waeber, B | 1 |
Brunner, HR; Burckhardt, P; Gavras, H; Waeber, B | 1 |
Braunwald, E; Darsee, JR; DeBoer, LW; Ertl, G; Glogar, DH; Ingwall, JS; Kloner, RA | 1 |
Bar-Andziak, E; Chlewicka, I | 1 |
Bozhko, AP; Solodkov, AP | 1 |
Gil-Extremera, B; González-Gómez, L; Luna del Castillo, JD; Maldonado-Martín, A; Rubio-Luengo, MA | 1 |
Ben-Ishay, D; Bursztyn, M; Fidel, J; Ghanem, J; Kobrin, I | 1 |
Collins, TJ; Mehra, MR; Ramee, SR; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
Barbee, RW; Conrad, K; Maymind, M; Zimmerman, R | 1 |
Cohen, EP; Fish, BL; Hill, P; Moulder, JE | 1 |
Drici, MD; Iacono, P; Jacomet, Y; Lapalus, P | 1 |
del Río Pérez, G; Fernández Vidal, P; Garrido García, J; Mora-Macià, J; Ocón Pujadas, J; Velasco Quintana, J | 1 |
Bujor, MA; Davis, BB; Myles, PS; Olenikov, I | 1 |
Arvidsson, N; Herlitz, H; Lukes, D; Mjörnstedt, L; Olausson, M | 2 |
Adachi, K; Hidaka, T; Muraishi, A; Okamoto, T; Seki, Y; Toshima, H | 1 |
Granger, JP; Schnackenberg, CG | 1 |
Brandt, D; Hofmann, R; Magometschnigg, D; Sihorsch, K; Stoschitzky, K; Zangeneh, M; Zenker, G | 1 |
Lopez, R; San Miguel, A; Taboada, C | 1 |
Dal Ponte, DB; Fogt, DL; Henriksen, EJ; Jacob, S | 1 |
Kähönen, M; Kööbi, T; Turjanmaa, V; Ylitalo, P; Ylitalo, R | 1 |
Atucha, NM; Cachofeiro, V; Fortepiani, LA; García-Estañ, J; Lahera, V; Ortíz, MC; Rodrigo, E; Ruilope, LM | 1 |
Jin, ZJ; Qi, JH; Wang, J; Wei, PJ; Zhang, L; Zhang, PJ | 1 |
Cifková, R; Compagnone, D; Hejl, Z; Nakov, R; Novozámská, E; Petrzílková, Z; Poledne, R; Stávek, P | 1 |
Iversen, BM; Myking, O; Ofstad, J; Svarstad, E | 1 |
Alberti, A; Corrada, E; Ferrari, S; Mafrici, A; Marenna, B | 1 |
Ghini, B; Lehfeld, LS; Lopes de Faria, JB; Silveira, LA | 1 |
Dali, MM; Heran, CL; Mathias, NR; Moench, PA; Smith, RL; Stetsko, PI | 1 |
Arnold, N; Marx, G; Rassler, B; Tannapfel, A; Ziegelhöffer-Mihalovicova, B; Zimmer, HG | 1 |
Eiger, G; Goldberg, S; Patel, NP; Pugh, ME | 1 |
7 review(s) available for captopril and verapamil
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Quality of life in the treatment of hypertension. The effect of calcium antagonists.
Topics: Calcium Channel Blockers; Captopril; Humans; Hypertension; Male; Nifedipine; Propranolol; Quality of Life; Verapamil | 1992 |
Calcium antagonists in the treatment of hypertension.
Topics: Biological Transport, Active; Calcium; Calcium Channel Blockers; Captopril; Diltiazem; Diuretics; Drug Resistance; Drug Therapy, Combination; Electrophysiology; Humans; Hypertension; Hypertension, Renovascular; Ion Channels; Kinetics; Methyldopa; Muscle, Smooth, Vascular; Nifedipine; Propranolol; Sodium; Vascular Resistance; Verapamil | 1985 |
Antihypertensive agents--the race for third place.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil | 1985 |
Hypertension--drug management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hypertension; Indoramin; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin; Sympatholytics; Vasodilator Agents; Verapamil | 1982 |
[New therapeutic approaches to arterial hypertension].
Topics: Angiotensin II; Benzothiadiazines; Calcium; Calcium Channel Blockers; Captopril; Diuretics; Drug Therapy, Combination; Humans; Hyperkalemia; Hypertension; Nifedipine; Renin-Angiotensin System; Sodium; Sodium Chloride Symporter Inhibitors; Vasodilation; Verapamil | 1982 |
17 trial(s) available for captopril and verapamil
Article | Year |
---|---|
Effects of treatment with verapamil SR and captopril on the lipid profile of hypertensive patients.
Topics: Blood Pressure; Captopril; Delayed-Action Preparations; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Lipid Metabolism; Lipids; Male; Middle Aged; Verapamil | 1992 |
Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Exercise; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Rest; Verapamil | 1992 |
Effects of captopril on blood pressure and respiratory function compared to verapamil in patients with hypertension and asthma.
Topics: Aged; Asthma; Blood Pressure; Captopril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Peak Expiratory Flow Rate; Respiration; Respiratory Function Tests; Verapamil; Vital Capacity | 1990 |
[Comparison of the efficacy and tolerability of sustained-release verapamil and captopril in mild to moderate essential arterial hypertension].
Topics: Adult; Captopril; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Verapamil | 1991 |
[Comparative efficacy of sustained release verapamil and captopril in mild to moderate arterial hypertension by ambulatory measurement and occasional measurement].
Topics: Adult; Aged; Ambulatory Care; Blood Pressure Determination; Blood Pressure Monitors; Captopril; Delayed-Action Preparations; Double-Blind Method; Humans; Hypertension; Middle Aged; Verapamil | 1991 |
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.
Topics: Adult; Aged; Atenolol; Black People; Captopril; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Renin; Supination; Verapamil | 1990 |
Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group.
Topics: Age Factors; Antihypertensive Agents; Atenolol; Black or African American; Black People; Captopril; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Quality of Life; Randomized Controlled Trials as Topic; Sex Factors; Verapamil | 1990 |
Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium channel blocker on blood pressure and respiratory function in patients with hypertension and asthma.
Topics: Aged; Asthma; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography; Female; Forced Expiratory Volume; Humans; Hypertension; Male; Middle Aged; Peak Expiratory Flow Rate; Random Allocation; Respiration; Verapamil | 1987 |
Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics.
Topics: Adult; Aged; Amiloride; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Nitrendipine; Proline; Renin; Renin-Angiotensin System; Spironolactone; Verapamil | 1985 |
Comparison of the efficacy of an ACE-inhibitor and a calcium channel blocker in hypertensive asthmatics. A preliminiary report.
Topics: Aged; Asthma; Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Random Allocation; Verapamil | 1986 |
Variations in magnesium and zinc in hypertensive patients receiving different treatments.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cholesterol, HDL; Erythrocytes; Female; Humans; Hypertension; Magnesium; Male; Middle Aged; Time Factors; Verapamil; Zinc | 1995 |
Comparison of verapamil and captopril in elderly hypertensive subjects: results of a randomized, double-blind, crossover study.
Topics: Aged; Analysis of Variance; Blood Pressure; Captopril; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Verapamil | 1993 |
Is verapamil also a non-selective beta blocker?
Topics: Adrenergic beta-Antagonists; Blood Pressure; Captopril; Cell Membrane; Double-Blind Method; Heart Rate; Humans; Hypertension; Lymphocytes; Radioligand Assay; Receptors, Adrenergic, beta; Single-Blind Method; Up-Regulation; Verapamil | 1993 |
[A clinical study of the verapamil and captopril combination in hypertensive patients uncontrolled by monotherapy. An evaluation by recording the 24-hour ambulatory blood pressure].
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Blood Pressure Monitors; Captopril; Circadian Rhythm; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Verapamil | 1993 |
Treatment of left ventricular hypertrophy in hypertensive patients with a combination of verapamil and captopril--a multicenter study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Verapamil | 1997 |
Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
Topics: Adult; Antihypertensive Agents; Arteries; Blood Pressure; Captopril; Cardiac Output; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Male; Propranolol; Pulsatile Flow; Pulse; Respiratory Mechanics; Verapamil | 1998 |
Evaluation of the effects of fixed combinations of sustained-release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Confidence Intervals; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Electrolytes; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lipoproteins; Male; Middle Aged; Treatment Outcome; Vasodilator Agents; Verapamil | 2000 |
62 other study(ies) available for captopril and verapamil
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Mitochondrial ATP synthase regulation in heart: defects in hypertension are restored after treatment with captopril.
Topics: Animals; Captopril; Cardiotonic Agents; Cells, Cultured; Electric Stimulation; Hypertension; Isoproterenol; Male; Mitochondria, Heart; Multienzyme Complexes; Myocardium; NADH, NADPH Oxidoreductases; Proton-Translocating ATPases; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ruthenium Red; Verapamil | 1992 |
[Comparative study of the action of Finoptin, Korinfar and Capoten in patients with stage II hypertensive disease].
Topics: Adult; Aged; Captopril; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Nifedipine; Verapamil | 1992 |
Tubuglomerular feedback control in long-looped nephrons. Topical minireview.
Topics: Animals; Captopril; Feedback; Glomerular Filtration Rate; Juxtaglomerular Apparatus; Kidney Concentrating Ability; Kidney Medulla; Nephrons; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Verapamil | 1992 |
Verapamil prevents insulin antinatriuresis in euglycemic rats.
Topics: Animals; Blood Glucose; Captopril; Insulin; Insulin Antagonists; Male; Natriuresis; Osmolar Concentration; Rats; Rats, Inbred Strains; Reference Values; Sodium; Verapamil | 1992 |
The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Captopril; Cell Division; Cilazapril; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix; Growth Substances; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Pyridazines; Rats; Verapamil | 1990 |
Renal functional reserve in treated and untreated hypertensive rats.
Topics: Animals; Captopril; Glycine; Hypertension, Renovascular; Kidney Function Tests; Kidney Glomerulus; Male; Punctures; Rats; Rats, Inbred Strains; Renal Circulation; Verapamil | 1991 |
[Progress in the treatment of myocardial diseases].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Diltiazem; Echocardiography; Electrocardiography; Female; Humans; Male; Middle Aged; Verapamil | 1990 |
Effects of angiotensin I converting enzyme inhibition and calcium channel blockade on plasma levels of active and inactive renin in conscious rabbits.
Topics: Angiotensin Amide; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium; Calcium Channel Blockers; Captopril; Consciousness; Feedback; Ion Channels; Juxtaglomerular Apparatus; Rabbits; Renin; Secretory Rate; Verapamil | 1987 |
Captopril inhibits the influx of calcium into platelets.
Topics: Blood Platelets; Calcimycin; Calcium; Calcium Radioisotopes; Captopril; Epinephrine; Humans; In Vitro Techniques; Verapamil | 1989 |
Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Captopril; Dogs; Female; Kidney; Male; Nifedipine; Vascular Resistance; Verapamil | 1986 |
[Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
Topics: Calcium Channel Blockers; Captopril; Drug Interactions; Enalapril; Humans; Hypertension; Nifedipine; Oligopeptides; Teprotide; Verapamil | 1986 |
Role of kininase II (ACE; E.C.3.4.15.1) in the regulation of renin secretion.
Topics: Angiotensin II; Animals; Captopril; Homeostasis; Kinetics; Peptidyl-Dipeptidase A; Rabbits; Renin; Renin-Angiotensin System; Verapamil | 1986 |
[Effect of the treatment with captopril and verapamil on left-ventricular function in patients with primary arterial hypertension].
Topics: Adult; Captopril; Female; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Verapamil | 1988 |
The protective effect of calcium inhibitors and of captopril on the renal microcirculation during reperfusion.
Topics: Angiotensin II; Animals; Calcium; Captopril; Dogs; Heparin; Kidney; Kidney Cortex; Kidney Glomerulus; Kidney Transplantation; Mannitol; Microcirculation; Organ Preservation; Perfusion; Trifluoperazine; Verapamil | 1987 |
Effects of cyclosporin on renal microcirculation.
Topics: Animals; Captopril; Cyclosporins; Glomerular Filtration Rate; Indomethacin; Kidney Glomerulus; Microcirculation; Rats; Rats, Inbred Strains; Renal Circulation; Renin-Angiotensin System; Verapamil | 1987 |
Influence of vasoactive substances on early toxic acute renal failure in the dog.
Topics: Acute Kidney Injury; Animals; Captopril; Dogs; Glomerular Filtration Rate; Imidazoles; Mercuric Chloride; Prostaglandins; Renal Circulation; Renin-Angiotensin System; Thromboxane B2; Time Factors; Verapamil | 1987 |
A combination of verapamil, captopril, and diuretic in the treatment of severe hypertension.
Topics: Adult; Captopril; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Verapamil | 1988 |
The combination of verapamil and captopril in the treatment of essential hypertension.
Topics: Captopril; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Verapamil | 1987 |
Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity.
Topics: Animals; Captopril; Cyclosporins; Glomerular Filtration Rate; Hemodynamics; Hormones; Indomethacin; Kidney Glomerulus; Male; Rats; Rats, Brattleboro; Rats, Inbred Strains; Verapamil | 1987 |
Effects of verapamil alone and with captopril on blood pressure and bilateral renal function in Goldblatt hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Glomerular Filtration Rate; Hypertension, Renovascular; Kidney; Male; Potassium; Rats; Rats, Inbred Strains; Sodium; Urodynamics; Verapamil | 1986 |
Antihypertensive drugs inhibit hypertension-associated aortic DNA synthesis in the rat.
Topics: Animals; Antihypertensive Agents; Captopril; DNA; Female; Hydralazine; Hypertension; Hypertension, Renal; Male; Muscle, Smooth, Vascular; Rats; Verapamil | 1986 |
The pathophysiology of the no-reflow phenomenon in cold-stored kidneys.
Topics: Animals; Calcium; Captopril; Cold Temperature; Dogs; Kidney; Renal Circulation; Tissue Preservation; Trifluoperazine; Verapamil | 1987 |
Influence of plasma renin content, intrarenal angiotensin II, captopril, and calcium channel blockers on the vasoconstriction and renin release promoted by adenosine in the kidney.
Topics: Adenosine; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Captopril; Diet, Sodium-Restricted; Dogs; Extracellular Space; Female; Kidney; Male; Propranolol; Renal Circulation; Renin; Vasoconstriction; Verapamil | 1985 |
[Therapy of cardiomyopathies].
Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Anticoagulants; Captopril; Cardiac Glycosides; Cardiomyopathies; Diet, Sodium-Restricted; Digitoxin; Digoxin; Dihydralazine; Diuretics; Humans; Nitrates; Practolol; Prenalterol; Temperance; Vasodilator Agents; Verapamil | 1982 |
New antihypertensive drugs. Angiotensin converting enzyme inhibitors and calcium antagonists.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Verapamil | 1984 |
[Evaluation of the efficacy of various hypotensive drugs in broad-breasted white turkeys as an experimental model of arterial hypertension with high catecholamine levels].
Topics: Animals; Antihypertensive Agents; Captopril; Catecholamines; Disease Models, Animal; Furosemide; Hypertension; Labetalol; Male; Oxprenolol; Rats; Turkeys; Verapamil | 1983 |
Hypertension in a patient with hypercalcemia: captopril and verapamil.
Topics: Adult; Captopril; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hypertension; Proline; Spironolactone; Verapamil | 1982 |
Observations on the experimental reduction of infarct size and on the delayed consequences of transient myocardial ischemia.
Topics: Animals; Captopril; Dogs; Fluorocarbons; Flurbiprofen; Myocardial Infarction; Myocardium; Necrosis; Verapamil | 1981 |
[New hypotensive drugs].
Topics: Antihypertensive Agents; Captopril; Drug Evaluation; Guanfacine; Guanidines; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Phenylacetates; Saralasin; Verapamil | 1981 |
[Effect of endogenous metabolites on autoregulation and dilational reserve of coronary vessels].
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Arginine; Captopril; Coronary Circulation; Coronary Vessels; Eicosanoids; Female; In Vitro Techniques; Indomethacin; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Vasodilation; Verapamil | 1993 |
An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Coronary Disease; Diltiazem; Enalapril; Female; Heart Transplantation; Humans; Hyperplasia; Lisinopril; Male; Middle Aged; Nifedipine; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional; Verapamil | 1995 |
Effect of verapamil and captopril on endothelial injury in the diabetic hypertensive rat.
Topics: Animals; Blood Pressure; Blood Vessels; Body Weight; Captopril; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hypertension; Male; Myocardium; Rats; Rats, Wistar; Tunica Media; Verapamil | 1994 |
Prophylaxis of experimental bone marrow transplant nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Transplantation; Captopril; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enalapril; Kidney; Kidney Diseases; Male; Proteinuria; Radiation Injuries, Experimental; Rats; Time Factors; Uremia; Verapamil; Whole-Body Irradiation | 1994 |
ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiopulmonary Bypass; Case-Control Studies; Coronary Artery Bypass; Critical Care; Diltiazem; Dopamine; Enalapril; Female; Heart Valves; Humans; Length of Stay; Male; Middle Aged; Nifedipine; Norepinephrine; Retrospective Studies; Single-Blind Method; Syndrome; Vascular Resistance; Verapamil | 1993 |
Rat heart allograft survival after treatment with verapamil, captopril, and enalapril.
Topics: Animals; Captopril; Drug Interactions; Enalapril; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Verapamil | 1995 |
Induction of DNA breaks in cardiac myoblast cells by norepinephrine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Captopril; DNA; DNA Damage; DNA, Single-Stranded; Heart; Hydrogen Peroxide; Myocardium; Norepinephrine; Propranolol; Quinazolines; Rats; Stimulation, Chemical; Verapamil | 1996 |
Verapamil abolishes the preglomerular response to ANG II during intrarenal nitric oxide synthesis inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Captopril; Dogs; Enzyme Inhibitors; Kidney; Kidney Glomerulus; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Regional Blood Flow; Vascular Resistance; Verapamil | 1997 |
Metabolic effects in rats of verapamil alone and in combination with captopril.
Topics: Alanine Transaminase; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Chemical Analysis; Blood Glucose; Calcium; Calcium Channel Blockers; Captopril; Glucose; Intestinal Absorption; Lipids; Male; Potassium; Rats; Rats, Sprague-Dawley; Verapamil | 1997 |
Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Calcium Channel Blockers; Captopril; Disease Models, Animal; Drug Interactions; Female; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Insulin; Insulin Resistance; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Oxidation-Reduction; Phosphorylation; Rats; Rats, Zucker; Verapamil | 1998 |
Prolonged rat heart allograft survival after treatment with angiotensin converting enzyme inhibitor or a calcium antagonist.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Captopril; Drug Therapy, Combination; Enalapril; Female; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Male; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Verapamil | 1998 |
Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of antihypertensive treatments.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Captopril; Enzyme Inhibitors; Hemodynamics; Hypertension; Male; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Verapamil | 1999 |
Effects of captopril and enalaprilat on intracellular Ca2+, Na+ contents and pH in hypoxic and reoxygenated cardiomyocytes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium Channel Blockers; Captopril; Cell Hypoxia; Enalaprilat; Hydrogen-Ion Concentration; Myocardium; Rats; Rats, Wistar; Sodium; Verapamil | 1997 |
Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
Topics: Adult; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Captopril; Enalapril; Exercise; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Circulation; Renal Plasma Flow, Effective; Verapamil | 2002 |
Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antimetabolites, Antineoplastic; Atrial Fibrillation; Captopril; Chest Pain; Colorectal Neoplasms; Coronary Angiography; Digoxin; Disease Management; Echocardiography; Electrocardiography; Fluorouracil; Humans; Laryngeal Neoplasms; Middle Aged; Myocardial Infarction; Nitrates; Verapamil | 2003 |
Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy.
Topics: Albuminuria; Amlodipine; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Synergism; Fibronectins; Glomerular Filtration Rate; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Verapamil | 2004 |
A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.
Topics: Administration, Sublingual; Animals; Captopril; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Models, Animal; Propranolol; Rabbits; Verapamil | 2006 |
Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Cardiomegaly; Collagen; Eating; Fibrosis; Hemodynamics; Lung; Male; Myocardium; Nuclease Protection Assays; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA; Sodium Chloride; Verapamil | 2006 |
Hyperinsulinemic euglycemia therapy for verapamil poisoning: case report.
Topics: Antidotes; Captopril; Critical Care; Drug Combinations; Female; Glyburide; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Middle Aged; Poisoning; Treatment Outcome; United States; Verapamil | 2007 |